London-listed Oxford Biomedica, a cell and gene therapy CDMO, has appointed Lucinda (Lucy) Crabtree as CFO and board member, replacing Stuart Paynter who will step down from the position after…
UK: Crabtree named as CFO at Oxford Biomedica
…
…






